Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

DRUG(1)
1 unique interventions1 categories

Analytics

Trial Phases

Phase 11

Trial Status

Completed1

Role Distribution

Other Roles1

Activity Timeline

Clinical Trials (1)

NCT03959189Phase 1Completed
Safety, Tolerability and Pharmacokinetics of ERX-963 in Adults With Myotonic Dystrophy Type 1
Myotonic DystrophyMyotonic Dystrophy, Type 1 (DM1)
StudydirectorStart date: 2019-06-17

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Chief Medical Officer

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Nicholas Johnson, MD

Virginia Commonwealth University

Moderately Similar
6 trials

Shared therapeutic areas:

Myotonic DystrophyMyotonic Dystrophy, Type 1 (DM1)
Similarity Score30%

Thierry Perez, MD

University Hospital, Lille

Related
2 trials

Shared therapeutic areas:

Myotonic Dystrophy
Similarity Score15%

Chiara Marini-Bettolo, MD, PhD

John Walton Muscular Dystrophy Research Centre

Related
2 trials

Shared therapeutic areas:

Myotonic Dystrophy
Similarity Score15%

Virginia Arechavala-Gomeza, Ph.D.

IIS Biobizkaia

Related
1 trials

Shared therapeutic areas:

Myotonic Dystrophy
Similarity Score15%

Wolfram Windisch, Pr

Lungen Klinik - Chefarzt Abt. Pneumologie Kliniken der StadtKölng GmbH, Ostmerheimer Strasse 200, Germany

Related
1 trials

Shared therapeutic areas:

Myotonic Dystrophy
Similarity Score15%

Djillali annane, MD, PhD

Assistance Publique Hôpitaux de Paris - University of Versailles

Related
4 trials

Shared therapeutic areas:

Myotonic Dystrophy
Similarity Score15%

Anita Simonds, Pr

NIHR Respiratory Biomedical Research Unit, Royal Brompton and Harefield NHS Foundation Trust, United Kingdom

Related
1 trials

Shared therapeutic areas:

Myotonic Dystrophy
Similarity Score15%

Denis Furling, Md, PhD

Université Paris 6 Pierre et Marie Curie

Related
1 trials

Shared therapeutic areas:

Myotonic Dystrophy
Similarity Score15%

Elise Duchesne, Ph.D

Université du Québec à Chicoutimi

Related
2 trials

Shared therapeutic areas:

Myotonic Dystrophy
Similarity Score15%

Truls Raastad, PhD

Norwegian School of Sport Sciences

Related
3 trials

Shared therapeutic areas:

Myotonic Dystrophy
Similarity Score15%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT03959189Phase 1StudyDirector

Safety, Tolerability and Pharmacokinetics of ERX-963 in Adults With Myotonic Dystrophy Type 1

Myotonic DystrophyMyotonic Dystrophy, Type 1 (DM1)
Completed

All 1 trials loaded